human papillomavirus

The vaccine against human papillomavirus (HPV), the sexually transmitted virus that causes cervical cancer, will be most cost-effective in the U.S. with universal vaccination of 12-year-old girls and catch-up efforts to vaccinate girls and women ages 13 to 21, researchers say.

Researchers have discovered that throat cancers linked to the human papillomavirus (HPV) respond better to cancer treatments than cancers not associated with HPV, a finding that's being lauded as a promising step toward tailored treatment.

HONOLULU -- Mothers were less willing to vaccinate their daughters against the human papillomavirus (HPV) during the optimal preteen years than at older ages, researchers found.

Persons with periodontitis who also are infected with human papillomavirus are at increased risk of developing tongue cancer, new research conducted at the University at Buffalo School of Dental Medicine has shown.

ATLANTA -- Nearly a quarter of the women receiving cervical screening were infected with high-risk strains of human papillomavirus (HPV), and many of those had normal Pap smears, a CDC study found.

Harald zur Hausen, D.Sc., M.D, internationally recognized for his research demonstrating the role of human papillomavirus as the etiological agent of cervical cancer, will receive the American Association of Cancer Research Award for Lifetime Achievement in honor of his life's work devoted to the study of the viruses and cancer.

TAMPA, Fla. -- Vaccination with the human papillomavirus quadrivalent vaccine (Gardasil) significantly reduced the frequency of abnormal Pap smears over four years and the need for cervical procedures and surgery, investigators reported here.